Terazosin Hydrochloride
Product Images NDC 71610-856

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 71610-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0856 80)

Terazosin Hydrochloride 2 mg capsules packaging label showing 180 capsules per container. The label includes storage instructions (20-25 degrees Celsius), dispensing instructions to store in a tight, light-resistant container, and manufacturing information by GSMs, Inc in Camarillo, CA. The product is labeled and packaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Terazosinhydrochloridechemicalstructure (Chemicalstructure)

Chemical structure of Terazosin Hydrochloride showing its molecular components, including methoxy groups, an amino group, and hydrochloride salt.*

FDA Label Image

Figure1 (Figure1)

Two line graphs comparing Terazosin and placebo effects over three months. The left graph shows mean change in total symptom score from baseline, with Terazosin decreasing symptoms more than placebo. The right graph shows mean increase in peak flow rate (mL/sec) from baseline, with Terazosin showing greater improvement compared to placebo.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the mean change from baseline over a period of 30 months. The x-axis represents the months from 0 to 30, while the y-axis indicates mean change values decreasing from 0 to -7. Data points are marked for each month, with notable declines in early months followed by a relatively stable trend, and several points are marked with asterisks.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting the mean change from baseline in mL/sec over a 30-month period. The x-axis represents time in months, ranging from 0 to 30, and the y-axis shows the mean change from baseline values from 0 to 4.5 mL/sec. Data points with error bars and statistical significance indicated by asterisks are displayed at several time points.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.